Remove 2023 Remove Heart Disease Remove Pulmonary
article thumbnail

Transpulmonary Expression of Exosomal microRNAs in Idiopathic and Congenital Heart Disease–Related Pulmonary Arterial Hypertension

Journal of the American Heart Association

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundPulmonary artery hypertension (PAH) is a fatal disease characterized by a complex pathogenesis. Transpulmonary exosomal miRs offer valuable insights into pulmonary circulation microenvironments.

article thumbnail

Hot Topics in Congenital and Pediatric Cardiology in the Year 2023

American College of Cardiology

This year saw exciting developments in the treatment of pediatric and congenital heart disease. Transcatheter pulmonary valve replacement (TPVR) continued to dominate the field of interventional cardiology.

article thumbnail

Avocados for the Heart; Cardiology's Sad State; CBD for Pulmonary Hypertension?

Heart 2023 Conference

Stroke) A Danish study indicated that combining nitrates and PDE5 inhibitors isn't always a terrible idea for men with ischemic heart disease and erectile dysfunction. JACC: Asia) Lexaria Bioscience has announced that a CBD product beats a placebo in simulating acute pulmonary hypertension.

article thumbnail

ECG Blog #366 — Diltiazem didn't work.

Ken Grauer, MD

These 2 settings are: i ) In patients with severe , often longstanding pulmonary disease ; and / or , ii ) In acutely ill patients with multi-system disease ( ie, sepsis, shock, electrolyte and/or acid-base disorders ). Acute Right Heart Strain. Hypoxic injury ( from pneumonia or other acute pulmonary complication ).

Blog 78
article thumbnail

FAQs about the Cardiology Recertification Exam

BoardVitals - Cardiovascular

The Cardiology MOC exam will be offered on April 3, 2023, and October 11, 2023. The Cardiology MOC exam covers the following subjects : Arrhythmias 15% Coronary Artery Disease 21.5% Pulmonary Circulation Disorders 3% Systemic Disorders Affecting the Circulatory System 7% How is the exam scored?

article thumbnail

Omics and Extreme Phenotyping Reveal Longitudinal Association Between Left Atrial Size and Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension

Journal of the American Heart Association

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundLeft heart disease is the most common cause of pulmonary hypertension (PH) and is frequently accompanied by increases in pulmonary vascular resistance.

article thumbnail

Transcatheter Palliation With Pulmonary Artery Flow Restrictors in Neonates With Congenital Heart Disease: Feasibility, Outcomes, and Comparison With a Historical Hybrid Stage 1 Cohort

Circulation: Cardiovascular Interventions

Background:Neonates with complex congenital heart disease and pulmonary overcirculation have been historically treated surgically. Pulmonary arteries grew adequately for age, and devices were easily removed without complications. However, subcohorts may benefit from less invasive procedures. kilograms [IQR, 2.1–3.3])